Notícias e Atividades da Pharmavite

A Pharmavite pertence à Otsuka Holdings.

Otsuka Holdings é uma das ...

• Forbes Global 2000 (#624);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Otsuka Holdings é uma empresa listada sob o símbolo 4578 (JP).

Otsuka Holdings tem presença direta em 11 países.

Otsuka Holdings possui 23 subsidiárias incluindo Araris Biotech, Cambridge Isotope Laboratories e Interpharma.

Eles estão dentro:

• Farmacêutica46%
• Equipamentos Médicos29%
• Outro25%

Veja o organograma con seus 22 executivos principais

Biografias mais buscadas da Pharmavite

• Jeff Boutelle, Chief Executive Officer and Director
• Tobe Cohen, President of Specialty Brands
• John Troup, Senior Vice President, Research & Development

Recentes movimentos de executivos em Pharmavite

• John Troup, ingressou na Companhia como Senior Vice President, Research & Development  (Notícia publicada em 12 de junho de 2026).

Criar um alerta
para seguir os movimentos de executivos da Pharmavite.

Otsuka Holdings possui 1.920 concorrentes concorrentes Sanofi (França), Moderna (Estados Unidos) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• Agenus acaba de anunciar uma arrecadação de fundos de 340 milhões de dólares. (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).

Outros contatos sugeridos na indústria do Farmacêutica

• David Ricks - President, Chief Executive Officer and Chairman of the Board da Eli Lilly
• Richard Saynor - Chief Executive Officer da Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board da Johnson & Johnson

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Pharmavite

• Nature Made® Tops U.S. News & World Report Best OTC Medicine & Health Products 2026 Rankings with More No. 1 Products Than Any Other Brand - Pharmavite
• Pharmavite Earns 2026 Great Place To Work® Certification™ - Pharmavite
• John Troup Joins Pharmavite as Senior Vice President, Research & Development - Pharmavite
• Uqora® Launches Flush Advanced+, an Innovative, Science-Backed Solution for Recurrent Urinary Tract Infections - Pharmavite
• MegaFood Unveils New Brand Campaign, Redefining How Quality Supplements Can Fit into Everyday Life - Pharmavite
• Bonafide® Health Launches Noctera™ – A Novel, Hormone-Free Supplement Designed to Improve Sleep Quality and Duration Negatively Impacted by Hormonal Changes - Pharmavite
• Nature Made® Continues Expansion of its Gut Health Offerings with the Launch of SuperGreens and Digestive Enzymes - Pharmavite
• Uqora® Launches Cutting-Edge Urinary Health Products at Target - Pharmavite
• Bonafide® Health Announces Expansion to Retail with Exclusive Launch into 1,800+ Target Stores and Target.com - Pharmavite
• Pharmavite Names Dr. Stewart Townsend Ph.D. as Senior Vice President, Research and Development - Pharmavite
• View more press releases Close

Redes sociais sobre Pharmavite

• Pharmavite na Wikipedia, Google News e Yahoo Finance
• Pharmavite na LinkedIn, X (Twitter) e YouTube